Skip to main content

Lebrikizumab Side Effects

Medically reviewed by Drugs.com. Last updated on Apr 10, 2025.

Applies to lebrikizumab: parenteral prefilled pen or syringe.

Side effects include:

Most common (≥1%) adverse reactions were conjunctivitis, injection site reactions, herpes zoster.

For healthcare professionals

Applies to lebrikizumab: subcutaneous solution.

Dermatologic adverse events

Hematologic

Local

Ocular

See also:

References

1. (2024) "Product Information. Ebglyss Pre-filled Pen (lebrikizumab)." Eli Lilly Canada Inc

Further information

Lebrikizumab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.